3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
4
Advanced Cancer
3
Uveal Melanoma
2
Recurrence
2
Lymphoma, Non-Hodgkin
2
Various Advanced Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Spinocerebellar Degenerations
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Microsatellite Unstable Colorectal Cancer
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Liver Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Glioma
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Brain Neoplasms
1
Advanced Gastric Cancer
1
Interventions
Gemcitabine
7
Cisplatin
5
Ramucirumab
3
Platinum
3
Paclitaxel
3
Docetaxel
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
Carboplatin
2
rucaparib
1
pegfilgrastim
1
pazopanib
1
eribulin
1
enzalutamide
1
enfortumab vedotin
1
dehydroftorafur
1
cabozantinib
1
avelumab
1
atezolizumab
1
aflibercept
1
Taxes
1
Surgical Procedures, Operative
1
Sunitinib
1
Standard of Care
1
Specimen Handling
1
Sorafenib
1
Radiotherapy
1
Radiation
1
N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide
1
Mitozytrex
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urethral Neoplasms
×
relatlimab
×
Clear all
No trials found.